scholarly journals Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial

2017 ◽  
Vol 40 (6) ◽  
pp. 390-398 ◽  
Author(s):  
Charles V. Pollack ◽  
Farideh Davoudi ◽  
Deborah B. Diercks ◽  
Richard C. Becker ◽  
Stefan K. James ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Relative Efficacy ◽  
Efficacy And Safety ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Elevation Acute Coronary Syndrome ◽  
Invasive Management

scholarly journals Anticoagulant therapy for non-ST-segment elevation acute coronary syndrome in China: A multi-center observational study

2016 ◽  
Vol 4 (1) ◽  
pp. 25-28 ◽  
Author(s):  
Xiao-huan Gong ◽  
Jin-ming Yu ◽  
Yong Mao ◽  
Da-yi Hu
Keyword(s):  
Acute Coronary Syndrome ◽  
Anticoagulant Therapy ◽  
Coronary Intervention ◽  
Efficacy And Safety ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Percutaneous Coronary ◽  
Elevation Acute Coronary Syndrome ◽  
Lower Incidence Rate

Abstract Objective To assess the anticoagulant therapy for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in China and to offer the rationale for establishing reasonable strategies to improve the prognosis of NSTE-ACS. Methods A total of 1,502 patients with NSTE-ACS were recruited from 28 third-grade hospitals distributed in 14 provinces and cities in China from December 2009 to December 2011. The strategies for diagnosis and treatment, decided by each hospital respectively, were used for further analysis and comparison of medication, percutaneous coronary intervention (PCI), and end points for efficacy and safety assessment at 9 and 30 days following PCI. Results A lower incidence rate (P < 0.05) was noted for efficacy and safety in patients with unstable angina (UA) than those with non-ST-segment elevation myocardial infarction (NSTE-MI). The prescription rate of unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), fondaparinux, PCI, and single medication was 0.61%, 66.42%, 30.61%, 69.64%, and 70.74%, respectively. Conclusion Compared with NSTE-MI, UA is featured with better prognosis, less severity, and different outcome. However, in clinical practice, the therapies for NSTE-MI and UA show no differences, which deserves great attention. In China, the most common anticoagulant therapies for NSTE-ACS are single medication, mainly based on LMWH and PCI.

Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome

2021 ◽  
Author(s):  
Pablo Díez‐Villanueva ◽  
Alberto Vera ◽  
Albert Ariza‐Solé ◽  
Francesc Formiga ◽  
Manuel Martínez‐Sellés ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Elevation Acute Coronary Syndrome

Prognostic Impact of Interventional Approach in Non-ST Segment Elevation Acute Coronary Syndrome in Very Elderly Patients

2011 ◽  
Vol 64 (10) ◽  
pp. 853-861 ◽  
Author(s):  
Iñaki Villanueva-Benito ◽  
Itziar Solla-Ruíz ◽  
Emilio Paredes-Galán ◽  
Óscar Díaz-Castro ◽  
Francisco E. Calvo-Iglesias ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Elderly Patients ◽  
Prognostic Impact ◽  
Very Elderly ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Elevation Acute Coronary Syndrome
Sign in / Sign up

Export Citation Format

Share Document